News & Articles

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination

Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep

Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects

New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives

New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier’

Kickstart your new year with this compilation of top eBooks, techniques, webinars and videos across a range of scientific topics

The new institute aims to meet the urgent need to do more research into the antimicrobial resistance

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Watch this on-demand webinar to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression

These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries

The novel self-labelling mammalian display method identifies antibodies against membrane proteins in their native configuration

Guest editorial: Technology to meet the needs of faster vaccine development